CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
Eligible age
18+ yrs
Accepts
All genders
Locations
4 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study is a prospective two-arm, single blind randomized controlled trial design to compare the clinical effectiveness of telemedicine-delivered, 6-session, standardized cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based treatment for insomnia (MBTI) in treating insomnia symptoms and ameliorating depressive symptoms in persons with mild to moderate TBI and comorbid Post-Traumatic Stress Symptoms (PTSS) and insomnia symptoms in a 360 patients. Participants will undergo assessment (psychosocial questionnaires, neurocognitive testing, sleep monitoring) at baseline, at the end of treatment, and at 2-, 6- and 12-weeks post-treatment. The primary outcome is sleep as measured by the Insomnia Severity Index (ISI).
Sponsor: Johns Hopkins University
You may qualify if…
- ✓ 1. Current or former member of the uniform services
- ✓ 2. Meet the Veterans Affairs Medical Center (VAMC) Department of Defense (DoD) criteria for TBI;
- ✓ 3. Time duration since traumatic brain injury (TBI) injury \>90 days
- ✓ 4. Insomnia symptom duration \>90 days
- ✓ 5. Endorse insomnia symptoms (Insomnia Severity Index \[ISI\] score \> 10)
- ✓ 6. Display sufficient cognitive capacity to provide informed consent (Montreal Cognitive Assessment (MoCA) Z-score \> -2)
- ✓ 7. \>18 years of age
- ✓ 8. Access to and ability and to use computer.
You may not qualify if…
- ✕ 1. History of neurological diseases other than TBI and not attributable to TBI
- ✕ 2. Sleep apnea \[apnea hypopnea index (AHI) \>15; individuals with mild apnea (AHI \> 5 and \<15) will be informed, but allowed to participate\]. Participants who use a continuous positive airway pressure (CPAP) device for sleep apnea will be eligible for participation if they are below the apnea/hypopnea cutoff while using CPAP, are adherent to using the device (\> 4 hours/night 21/30 consecutive days) and agree to continue using the device during study participation.
- ✕ 3. Lastly, people using psychotropic medications may be included if they are on a stable dosage for the last three weeks prior to the study.
Where it's recruiting
Source: ClinicalTrials.gov · NCT05663034 · last updated 2026-05-28